CYP2C9 antibody selection within a family that shares most of its sequence

Specifying and controlling the reagent

1. Demand cross-reactivity data against the family, by name. The useful evidence is a panel of recombinant family members blotted side by side, showing the antibody detects one and not the others. A datasheet naming only the intended target has not addressed the question that matters for this family.
2. Prepare microsomes rather than whole lysate. These enzymes sit in the endoplasmic reticulum membrane, so a microsomal preparation concentrates them substantially against soluble protein. It is a centrifugation step and it usually makes more difference than any change of antibody.
3. Do not over-denature a membrane enzyme. As with other membrane proteins, hard boiling promotes aggregation. A lower denaturation temperature is worth testing before concluding the reagent does not work, and a lane that shows material stuck in the well is the diagnostic.
4. Use recombinant enzyme as the positive and a null system as the negative. Single-enzyme recombinant preparations are widely available and make an unambiguous positive control. A system expressing none of the family is the corresponding negative, and together they settle specificity far better than tissue alone.
5. Consider whether activity is the real question. A selective probe substrate measured by chromatography reports what the enzyme does, which is usually what a study needs, and it distinguishes family members by their catalytic selectivity rather than by an epitope. Protein level and activity frequently diverge.

Induction studies and what they need

Where the question is whether a compound induces an enzyme, both protein and activity should move together and transcript usually moves first. Measuring all three across a time course is what makes an induction claim defensible.

Include a known inducer as a positive control at a known concentration. Induction experiments without one cannot distinguish a compound that does not induce from an assay that would not have detected it.

Species differences are large here

The family differs substantially between species in both membership and substrate selectivity, so an antibody validated in human material may detect nothing, or something else, in a model organism. Ask for tested rather than predicted reactivity.

The same caution applies to extrapolating biology: a metabolic route in one species is frequently not the route in another, which is the whole reason these measurements are made.

Buying and recording

Prefer a monoclonal or recombinant reagent with published cross-reactivity data, buy one lot for a study, and record the catalogue number and lot with every experiment. Polyclonal reagents against this family are particularly prone to lot variation in their cross-reactivity.

Keep the recombinant enzyme controls in the freezer alongside. Re-checking specificity when a new lot arrives takes one gel and removes the largest uncertainty in the measurement.

An aromatase antibody or CYP17A1 antibody needs tissue context

Enzymes in the steroid pathway are abundant in a few tissues and present at low levels in many others, and the low-level expression is usually the interesting part. A reagent validated on a high-expressing tissue can be useless where the question is whether a trace amount is present at all.

Positive and negative control tissues are therefore not optional, and they belong in the same run as the samples. Where the claim is local production of a hormone, the protein stain is one line of evidence and a measurement of the product is the other; neither carries the claim alone.

Enzymes with a near-identical relative

Some metabolic enzymes have a close paralogue that shares most of its sequence, runs at the same size and is expressed in overlapping tissues. An antibody sold against one may detect both, and the product page will often say only that it was raised against a peptide from the intended target.

Ask which relatives were tested and with what result, read the immunogen against an alignment, and where the distinction carries the conclusion, confirm it in a system lacking each one. This is the same discipline the drug-metabolising family demands, and for the same reason.

An abca1 antibody and a very large lipid transporter

ABCA1 moves cholesterol and phospholipid onto acceptors and is the protein behind reverse cholesterol transport, so an abca1 antibody is read as expression against a stated loading reference rather than as an activity. It is a large multipass protein, which means no boiling, a membrane preparation and a long transfer, and a missing band on a first attempt is usually the transfer rather than the antibody.

An abcg1 antibody beside it in the same pathway

ABCG1 acts on a later step of the same efflux pathway and is regulated by the same nuclear receptors, so an abcg1 antibody belongs in a figure with its partner rather than alone, and an agonist treated lane is the control that shows both respond. It is glycosylated and multipass, so the band is broad, and the family shares sequence enough that the immunogen matters.

An scd1 antibody and an enzyme that tracks diet

SCD1 desaturates fatty acids and its expression moves with nutritional state and with the nuclear receptor programme above it, so an scd1 antibody reads a condition rather than a fixed property and the feeding or starvation protocol is part of the method. It is an endoplasmic reticulum membrane enzyme, so the microsomal fraction is where it is cleanly seen, and the product to substrate ratio is the functional readout.

An fasn antibody and a large multidomain enzyme

Fatty acid synthase is a single very large polypeptide that works as a dimer, so an fasn antibody reports a band far above most of the gel and needs a low percentage separation. Expression is high in lipogenic tissue and in many tumours, which is why it is read as a comparison between lines with a stated loading reference. Activity belongs to an enzyme assay rather than to the blot.

A fatty acid synthase antibody, the same enzyme spelled out

A fatty acid synthase antibody and an antibody against the gene symbol are the same reagent under two catalogue conventions, so searching one name hides part of the market. What differs between clones is the domain the immunogen came from, which matters because the protein is cleaved in some tissues and because a domain specific clone may miss a truncated form.

Common questions

How do I know a cyp2c9 antibody is specific?

By a blot of recombinant family members side by side showing detection of the target and not its close relatives. Within this family, sequence identity is high enough that specificity has to be demonstrated rather than assumed.

Why is my CYP2E1 antibody signal weak in liver lysate?

Whole lysate dilutes a membrane enzyme with abundant soluble protein. Prepare microsomes, and check the denaturation temperature, because these enzymes aggregate when boiled hard.

Should I measure protein or activity?

Activity, usually. A selective probe substrate measured by chromatography reports function and distinguishes family members catalytically. Protein level and activity diverge often enough that the choice matters.

Can these antibodies be used for immunohistochemistry?

Some are validated for it, and the same cross-reactivity question applies with less ability to check by size. Ask for staining in a tissue with a known expression pattern and, ideally, alongside a null control.

Is a protein blot evidence of enzyme activity?

No. Activity depends on localisation, cofactors, modification and inhibitors as well as on how much protein is present. If the claim concerns flux, measure activity or a product and use the blot as supporting evidence.

Browse by service class

• Compare Gene synthesis on advertised prices